Skip to content

Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus

Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04011566
Enrollment
50
Registered
2019-07-08
Start date
2019-06-11
Completion date
2026-11-01
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus, Normal Pressure

Keywords

Asymptomatic Normal Pressure Hydrocephalus, Ventriculoperitoneal Shunt

Brief summary

The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with asymptomatic normal pressure hydrocephalus.

Interventions

DIAGNOSTIC_TESTShuntCheck

The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.

Sponsors

University of South Florida
Lead SponsorOTHER
NeuroDx Development
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Asymptomatic men or women 40 years old or older and have a ventriculoperitoneal shunt placed for normal pressure hydrocephalus and are visiting for routine care. * Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker capable of providing valid, signed informed consent.

Exclusion criteria

* Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction; * ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated; * Presence of an interfering open wound or edema over any portion of the ventriculoperitoneal shunt.

Design outcomes

Primary

MeasureTime frame
Specificity of ShuntCheck test15 minutes
Negative Predictive Value of ShuntCheck test15 minutes

Secondary

MeasureTime frame
Specificity of performing ShuntCheck test twice60 minutes
Negative Predictive Value of performing ShuntCheck test twice60 minutes

Countries

United States

Contacts

CONTACTNaomi Abel, MD
nabel@usf.edu813 259-0904
CONTACTRachel Karlnoski, MD
Karlnosk@usf.edu813 974 8558
PRINCIPAL_INVESTIGATORNaomi Abel, MD

University of South Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026